跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fresofol 1% MCT/LCT Propofol 500mg/50mL Emulsion for Intravenous Injection/Infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
Fresofol 1% MCT/LCT Propofol 500mg/50mL Emulsion for Intravenous Injection/Infusion vial
Approved
STANDARD
Fresofol 1% MCT/LCT Propofol 500mg/50mL Emulsion for Intravenous Injection/Infusion vial
Fresenius Kabi Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
6db464702ca56db2
Company
Fresenius Kabi Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
6db464702ca56db2
Product Name
Fresofol 1% MCT/LCT Propofol 500mg/50mL Emulsion for Intravenous Injection/Infusion vial
Artg Id
193609
Artg Name
FRESOFOL 1% MCT/LCT propofol 500mg/50mL emulsion for intravenous injection/infusion vial
Sponsor
Fresenius Kabi Australia Pty Ltd
Company Detail Path
/organization/fresenius-kabi-australia-pty-ltd
Artg Date
2012-11-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ec3799c3ce25ebcbec61ffea5ea7af0e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/fad1ccf93317a3879242409aa91de5f0.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
6db464702ca56db2
Type
Standard
Back to TGA Approvals